The mu1 and mu2 opioid receptor binding of ketobemidone, norketobemidone and 3-dimethylamino-1,1-diphenylbutene.
Kristensen
K
K
Department of Bioanalytical Development, H. Lundbeck A/S, Valby, Denmark.
Christensen
C B
CB
Christrup
L L
LL
Nielsen
L C
LC
D000499:Allylamine / Q000031:analogs & derivatives / Q000378:metabolism; D000701:Analgesics, Opioid / Q000378:metabolism*; D000818:Animals; D001667:Binding, Competitive; D002417:Cattle; D002421:Caudate Nucleus / Q000378:metabolism; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D020881:Enkephalin, D-Penicillamine (2,5)-; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives / Q000378:metabolism; D016308:Enkephalin, Leucine-2-Alanine / Q000378:metabolism; D004745:Enkephalins / Q000378:metabolism; D006801:Humans; D007540:Isonipecotic Acids / Q000378:metabolism*; D008614:Meperidine / Q000031:analogs & derivatives* / Q000378:metabolism; D010276:Parasympatholytics / Q000378:metabolism*; D010636:Phenols / Q000378:metabolism*; D017465:Receptors, Opioid, delta / Q000819:agonists; D017450:Receptors, Opioid, mu / Q000378:metabolism*
D000701:Analgesics, Opioid; D004745:Enkephalins; D007540:Isonipecotic Acids; D010276:Parasympatholytics; D010636:Phenols; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; C011044:norketobemidone; D000499:Allylamine; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; C034318:enkephalin, Ser(2), Leu(5), Thr(6)-; D020881:Enkephalin, D-Penicillamine (2,5)-; D008614:Meperidine; C029665:N,N-dimethyl-3,3-diphenyl-1-methylallylamine; C012394:ketobemidone